Harte Hanks Reports Q1 2026 Results: Revenue Down 10.3%, Net Loss Worsens 60.2% Amid Operational Challenges
summarizeSummary
Harte Hanks reported a 10.3% revenue decrease and a 60.2% higher net loss in Q1 2026, with operating losses widening significantly, though operating cash burn improved and substantial credit remains available.
check_boxKey Events
-
Q1 2026 Revenue Decline
Revenue decreased by 10.3% to $37.3 million in Q1 2026, down from $41.6 million in Q1 2025, with all segments experiencing declines.
-
Worsening Net Loss
Net loss increased by 60.2% to $0.6 million in Q1 2026, compared to a net loss of $0.4 million in the prior year quarter.
-
Significant Operating Loss Increase
Operating loss widened substantially to $0.8 million in Q1 2026 from $0.04 million in Q1 2025, indicating a deterioration in core operational performance.
-
Improved Operating Cash Flow
Net cash used in operating activities improved to $0.6 million in Q1 2026, compared to $0.8 million used in Q1 2025.
auto_awesomeAnalysis
Harte Hanks' Q1 2026 results show a significant 10.3% revenue decline and a 60.2% increase in net loss compared to the prior year, indicating worsening profitability. The operating loss widened substantially from $0.04 million to $0.77 million, reflecting core operational challenges. While cash and equivalents decreased, the company improved its net cash used in operating activities, and maintains a substantial $24.3 million in available credit, providing a buffer against current losses. This detailed quarterly report follows a high-level announcement, providing critical insights into the company's financial health and segment performance.
At the time of this filing, HHS was trading at $2.81 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $20.8M. The 52-week trading range was $2.22 to $5.39. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.